Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Revenue

Vistagen Therapeutics had revenue of $303.00K in the quarter ending December 31, 2025, with 29.49% growth. This brings the company's revenue in the last twelve months to $914.50K, up 31.02% year-over-year. In the fiscal year ending March 31, 2025, Vistagen Therapeutics had annual revenue of $486.00K, down -54.32%.

• Revenue (ttm): $914.50K
• Revenue Growth: +31.02%
• P/S Ratio: 31.21
• Revenue / Employee: $13,373
• Employees: 59
• Market Cap: 24.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	486.00K	-578.00K	-54.32%
Mar 31, 2024	1.06M	1.29M	-
Mar 31, 2023	-227.00K	-1.34M	-
Mar 31, 2022	1.11M	19.40K	1.78%
Mar 31, 2021	1.09M	-	-
Mar 31, 2020	-	-	-
Mar 31, 2019	-	-	-
Mar 31, 2018	-	-	-
Mar 31, 2017	1.25M	-	-
Mar 31, 2016	-	-	-
Mar 31, 2015	-	-	-
Mar 31, 2014	-	-	-
Mar 31, 2013	200.40K	-1.14M	-85.07%
Mar 31, 2012	1.34M	-728.80K	-35.19%
Mar 31, 2011	2.07M	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-

Data Source: Fiscal.ai Last updated: Feb 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 13, 2026

Data Sources Report a data error